Literature DB >> 17971613

Abnormal fatty alcohol metabolism in cultured keratinocytes from patients with Sjögren-Larsson syndrome.

William B Rizzo1, Debra A Craft, Tara Somer, Gael Carney, Juliana Trafrova, Marcia Simon.   

Abstract

Sjögren-Larsson syndrome (SLS) is an inherited neurocutaneous disorder characterized by ichthyosis, mental retardation, spasticity, and deficient activity of fatty aldehyde dehydrogenase (FALDH). FALDH is an enzyme component of fatty alcohol:NAD oxidoreductase (FAO), which is necessary for fatty alcohol metabolism. To better understand the biochemical basis for the cutaneous symptoms in this disease, we investigated lipid metabolism in cultured keratinocytes from SLS patients. Enzyme activities of FALDH and FAO in SLS cells were <10% of normal. SLS keratinocytes accumulated 45-fold more fatty alcohol (hexadecanol, octadecanol, and octadecenol) than normal, whereas wax esters and 1-O-alkyl-2,3-diacylglycerols were increased by 5.6-fold and 7.5-fold, respectively. SLS keratinocytes showed a reduced incorporation of radioactive octadecanol into fatty acid (24% of normal) and triglyceride (13% of normal), but incorporation into wax esters and 1-O-alkyl-2,3-diacylglycerol was increased by 2.5-fold and 2.8-fold, respectively. Our results indicate that FALDH deficiency in SLS keratinocytes causes the accumulation and diversion of fatty alcohol into alternative biosynthetic pathways. The striking lipid abnormalities in cultured SLS keratinocytes are distinct from those seen in fibroblasts and may be related to the stratum corneum dysfunction and ichthyosis in SLS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17971613      PMCID: PMC3057183          DOI: 10.1194/jlr.M700469-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  51 in total

Review 1.  Plasmalogens: biosynthesis and functions.

Authors:  N Nagan; R A Zoeller
Journal:  Prog Lipid Res       Date:  2001-05       Impact factor: 16.195

2.  Defective inactivation of leukotriene B4 in patients with Sjögren-Larsson syndrome.

Authors:  M A Willemsen; J G de Jong; P H van Domburg; J J Rotteveel; R J Wanders; E Mayatepek
Journal:  J Pediatr       Date:  2000-02       Impact factor: 4.406

Review 3.  Sjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency.

Authors:  William B Rizzo
Journal:  Mol Genet Metab       Date:  2006-09-22       Impact factor: 4.797

Review 4.  Calcium- and vitamin D-regulated keratinocyte differentiation.

Authors:  D D Bikle; D Ng; C L Tu; Y Oda; Z Xie
Journal:  Mol Cell Endocrinol       Date:  2001-05-25       Impact factor: 4.102

Review 5.  1,25-Dihydroxyvitamin D(3), phospholipase D and protein kinase C in keratinocyte differentiation.

Authors:  W Bollinger Bollag; R J Bollag
Journal:  Mol Cell Endocrinol       Date:  2001-05-25       Impact factor: 4.102

6.  Microsomal fatty aldehyde dehydrogenase catalyzes the oxidation of aliphatic aldehyde derived from ether glycerolipid catabolism: implications for Sjögren-Larsson syndrome.

Authors:  W B Rizzo; E Heinz; M Simon; D A Craft
Journal:  Biochim Biophys Acta       Date:  2000-12-15

Review 7.  Lipids and barrier function of the skin.

Authors:  P W Wertz
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  2000

8.  Plasmalogen degradation by oxidative stress: production and disappearance of specific fatty aldehydes and fatty alpha-hydroxyaldehydes.

Authors:  S Stadelmann-Ingrand; S Favreliere; B Fauconneau; G Mauco; C Tallineau
Journal:  Free Radic Biol Med       Date:  2001-11-15       Impact factor: 7.376

9.  Defective metabolism of leukotriene B4 in the Sjögren-Larsson syndrome.

Authors:  M A Willemsen; J J Rotteveel; J G de Jong; R J Wanders; L IJlst; G F Hoffmann; E Mayatepek
Journal:  J Neurol Sci       Date:  2001-01-15       Impact factor: 3.181

Review 10.  Ceramides and skin function.

Authors:  Luisa Coderch; Olga López; Alfonso de la Maza; José L Parra
Journal:  Am J Clin Dermatol       Date:  2003       Impact factor: 7.403

View more
  17 in total

1.  Disruption of the Sjögren-Larsson Syndrome Gene Aldh3a2 in Mice Increases Keratinocyte Growth and Retards Skin Barrier Recovery.

Authors:  Tatsuro Naganuma; Shuyu Takagi; Tsukasa Kanetake; Takuya Kitamura; Satoko Hattori; Tsuyoshi Miyakawa; Takayuki Sassa; Akio Kihara
Journal:  J Biol Chem       Date:  2016-04-06       Impact factor: 5.157

2.  Large contiguous gene deletions in Sjögren-Larsson syndrome.

Authors:  Holly Engelstad; Gael Carney; Dana S'aulis; Janae Rise; Warren G Sanger; M Katharine Rudd; Gabriele Richard; Christopher W Carr; Omar A Abdul-Rahman; William B Rizzo
Journal:  Mol Genet Metab       Date:  2011-05-30       Impact factor: 4.797

3.  The acyl-CoA binding protein is required for normal epidermal barrier function in mice.

Authors:  Maria Bloksgaard; Signe Bek; Ann-Britt Marcher; Ditte Neess; Jonathan Brewer; Hans Kristian Hannibal-Bach; Torben Helledie; Christina Fenger; Marianne Due; Zane Berzina; Reinhard Neubert; John Chemnitz; Bente Finsen; Anders Clemmensen; Johannes Wilbertz; Henrik Saxtorph; Jens Knudsen; Luis Bagatolli; Susanne Mandrup
Journal:  J Lipid Res       Date:  2012-07-24       Impact factor: 5.922

Review 4.  Plasmalogens and fatty alcohols in rhizomelic chondrodysplasia punctata and Sjögren-Larsson syndrome.

Authors:  Ana R Malheiro; Tiago Ferreira da Silva; Pedro Brites
Journal:  J Inherit Metab Dis       Date:  2014-11-29       Impact factor: 4.982

5.  Phenotypic and mutational spectrum of thirty-five patients with Sjögren-Larsson syndrome: identification of eleven novel ALDH3A2 mutations and founder effects.

Authors:  Mohamed S Abdel-Hamid; Mahmoud Y Issa; Hasnaa M Elbendary; Sherif F Abdel-Ghafar; Karima Rafaat; Heba Hosny; Marian Girgis; Ghada M H Abdel-Salam; Maha S Zaki
Journal:  J Hum Genet       Date:  2019-07-05       Impact factor: 3.172

6.  RP-HPLC-fluorescence analysis of aliphatic aldehydes: application to aldehyde-generating enzymes HACL1 and SGPL1.

Authors:  Serena Mezzar; Evelyn de Schryver; Paul P Van Veldhoven
Journal:  J Lipid Res       Date:  2013-12-09       Impact factor: 5.922

7.  Genetics and prospective therapeutic targets for Sjögren-Larsson Syndrome.

Authors:  William B Rizzo
Journal:  Expert Opin Orphan Drugs       Date:  2016-03-10       Impact factor: 0.694

8.  1-O-Alkylglycerol accumulation reveals abnormal ether glycerolipid metabolism in Sjögren-Larsson syndrome.

Authors:  Dana S'aulis; Emily A Khoury; Morgan Zabel; William B Rizzo
Journal:  Mol Genet Metab       Date:  2020-08-12       Impact factor: 4.797

Review 9.  Fatty aldehyde and fatty alcohol metabolism: review and importance for epidermal structure and function.

Authors:  William B Rizzo
Journal:  Biochim Biophys Acta       Date:  2013-09-12

10.  Ichthyosis in Sjögren-Larsson syndrome reflects defective barrier function due to abnormal lamellar body structure and secretion.

Authors:  William B Rizzo; Dana S'Aulis; M Anitia Jennings; Debra A Crumrine; Mary L Williams; Peter M Elias
Journal:  Arch Dermatol Res       Date:  2010-01-05       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.